Skip to main content
Top
Published in: Current Atherosclerosis Reports 10/2013

01-10-2013 | Clinical Trials and Their Interpretations (J Plutzky, Section Editor)

Imaging Atherosclerosis and Risk of Plaque Rupture

Authors: Eric A. Osborn, Farouc A. Jaffer

Published in: Current Atherosclerosis Reports | Issue 10/2013

Login to get access

Abstract

Atherosclerosis imaging strategies can delineate characteristics of plaques at risk of rupture and thrombosis. Structural plaque imaging identifies high-risk plaque features, including lipid pools, thin fibrous caps, and intraplaque hemorrhage. New molecular imaging techniques complement structural imaging approaches by illuminating important features of plaque biology, with a prominent focus on detecting inflammation as a high-risk phenotype. As we unravel the molecular and structural characteristics underlying thrombosis-prone plaques, there is significant promise for eventual early identification and prediction of atherosclerotic plaque complications before they occur. Here we focus on recent imaging insights into high-risk arterial plaques, the etiologic agent of acute myocardial infarction, stroke, and sudden cardiac death.
Literature
1.
go back to reference Fleg JL, Stone GW, Fayad ZA, et al. Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions. JACC Cardiovasc Imaging. 2012;5(9):941–55.PubMedCrossRef Fleg JL, Stone GW, Fayad ZA, et al. Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions. JACC Cardiovasc Imaging. 2012;5(9):941–55.PubMedCrossRef
2.
go back to reference Arbab-Zadeh A, Nakano M, Virmani R, Fuster V. Acute coronary events. Circulation. 2012;125(9):1147–56.PubMedCrossRef Arbab-Zadeh A, Nakano M, Virmani R, Fuster V. Acute coronary events. Circulation. 2012;125(9):1147–56.PubMedCrossRef
3.
go back to reference •• Narula J, Nakano M, Virmani R, et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol. 2013;61(10):1041–51. This contains an extensive postmortem histomorphometric characterization of human coronary artery plaques from sudden cardiac death subjects. These high-risk plaque findings are potential targets for in vivo plaque imaging approaches.PubMedCrossRef •• Narula J, Nakano M, Virmani R, et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol. 2013;61(10):1041–51. This contains an extensive postmortem histomorphometric characterization of human coronary artery plaques from sudden cardiac death subjects. These high-risk plaque findings are potential targets for in vivo plaque imaging approaches.PubMedCrossRef
4.
go back to reference Nance Jr JW, Schlett CL, Schoepf UJ, et al. Incremental prognostic value of different components of coronary atherosclerotic plaque at cardiac CT angiography beyond coronary calcification in patients with acute chest pain. Radiology. 2012;264(3):679–90.PubMedCrossRef Nance Jr JW, Schlett CL, Schoepf UJ, et al. Incremental prognostic value of different components of coronary atherosclerotic plaque at cardiac CT angiography beyond coronary calcification in patients with acute chest pain. Radiology. 2012;264(3):679–90.PubMedCrossRef
5.
go back to reference • Aldrovandi A, Cademartiri F, Arduini D, et al. Computed tomography coronary angiography in patients with acute myocardial infarction without significant coronary stenosis. Circulation. 2012;126(25):3000–7. Acute coronary syndrome patients had a greater number of nonobstructive plaques in infarct-related arteries with high-risk features (fibrofatty or mixed fibrous/calcified composition) as determined by MDCTA.PubMedCrossRef • Aldrovandi A, Cademartiri F, Arduini D, et al. Computed tomography coronary angiography in patients with acute myocardial infarction without significant coronary stenosis. Circulation. 2012;126(25):3000–7. Acute coronary syndrome patients had a greater number of nonobstructive plaques in infarct-related arteries with high-risk features (fibrofatty or mixed fibrous/calcified composition) as determined by MDCTA.PubMedCrossRef
6.
go back to reference van den Bouwhuijsen QJ, Vernooij MW, Hofman A, et al. Determinants of magnetic resonance imaging detected carotid plaque components: the Rotterdam Study. Eur Heart J. 2012;33(2):221–9.PubMedCrossRef van den Bouwhuijsen QJ, Vernooij MW, Hofman A, et al. Determinants of magnetic resonance imaging detected carotid plaque components: the Rotterdam Study. Eur Heart J. 2012;33(2):221–9.PubMedCrossRef
7.
go back to reference Freilinger TM, Schindler A, Schmidt C, et al. Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. JACC Cardiovasc Imaging. 2012;5(4):397–405.PubMedCrossRef Freilinger TM, Schindler A, Schmidt C, et al. Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. JACC Cardiovasc Imaging. 2012;5(4):397–405.PubMedCrossRef
8.
go back to reference Lindsay AC, Biasiolli L, Lee JM, et al. Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case–control, 3-T carotid artery MR imaging study. JACC Cardiovasc Imaging. 2012;5(4):388–96.PubMedCrossRef Lindsay AC, Biasiolli L, Lee JM, et al. Plaque features associated with increased cerebral infarction after minor stroke and TIA: a prospective, case–control, 3-T carotid artery MR imaging study. JACC Cardiovasc Imaging. 2012;5(4):388–96.PubMedCrossRef
9.
go back to reference Sun J, Underhill HR, Hippe DS, et al. Sustained acceleration in carotid atherosclerotic plaque progression with intraplaque hemorrhage: a long-term time course study. JACC Cardiovasc Imaging. 2012;5(8):798–804.PubMedCrossRef Sun J, Underhill HR, Hippe DS, et al. Sustained acceleration in carotid atherosclerotic plaque progression with intraplaque hemorrhage: a long-term time course study. JACC Cardiovasc Imaging. 2012;5(8):798–804.PubMedCrossRef
10.
go back to reference Turc G, Oppenheim C, Naggara O, et al. Relationships between recent intraplaque hemorrhage and stroke risk factors in patients with carotid stenosis: the HIRISC study. Arterioscler Thromb Vasc Biol. 2012;32(2):492–9.PubMedCrossRef Turc G, Oppenheim C, Naggara O, et al. Relationships between recent intraplaque hemorrhage and stroke risk factors in patients with carotid stenosis: the HIRISC study. Arterioscler Thromb Vasc Biol. 2012;32(2):492–9.PubMedCrossRef
11.
go back to reference Kataoka Y, Wolski K, Uno K, et al. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound. J Am Coll Cardiol. 2012;59(18):1592–7.PubMedCrossRef Kataoka Y, Wolski K, Uno K, et al. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound. J Am Coll Cardiol. 2012;59(18):1592–7.PubMedCrossRef
12.
go back to reference Matsuo Y, Takumi T, Mathew V, et al. Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems. Atherosclerosis. 2012;223(2):365–71.PubMedCrossRef Matsuo Y, Takumi T, Mathew V, et al. Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems. Atherosclerosis. 2012;223(2):365–71.PubMedCrossRef
13.
go back to reference Maehara A, Cristea E, Mintz GS, et al. Definitions and methodology for the grayscale and radiofrequency intravascular ultrasound and coronary angiographic analyses. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S1–9.PubMedCrossRef Maehara A, Cristea E, Mintz GS, et al. Definitions and methodology for the grayscale and radiofrequency intravascular ultrasound and coronary angiographic analyses. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S1–9.PubMedCrossRef
14.
go back to reference •• Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226–35. This is a prospective study of 697 patients with acute coronary syndrome imaged with three-vessel IVUS and followed for clinical events over more than 3 years. Nearly half of the 20.6% of recurrent events occurred in nonculprit lesions, with multivariable analysis identifying plaque burden greater than 70%, minimal lumen area less than 4.0 mm 2 , and VH IVUS TCFAs as additive predictors of adverse outcomes.PubMedCrossRef •• Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226–35. This is a prospective study of 697 patients with acute coronary syndrome imaged with three-vessel IVUS and followed for clinical events over more than 3 years. Nearly half of the 20.6% of recurrent events occurred in nonculprit lesions, with multivariable analysis identifying plaque burden greater than 70%, minimal lumen area less than 4.0 mm 2 , and VH IVUS TCFAs as additive predictors of adverse outcomes.PubMedCrossRef
15.
go back to reference McPherson JA, Maehara A, Weisz G, et al. Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S76–85.PubMedCrossRef McPherson JA, Maehara A, Weisz G, et al. Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S76–85.PubMedCrossRef
16.
go back to reference Sanidas EA, Mintz GS, Maehara A, et al. Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S95–105.PubMedCrossRef Sanidas EA, Mintz GS, Maehara A, et al. Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S95–105.PubMedCrossRef
17.
go back to reference Brugaletta S, Garcia-Garcia HM, Serruys PW, et al. Relationship between palpography and virtual histology in patients with acute coronary syndromes. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S19–27.PubMedCrossRef Brugaletta S, Garcia-Garcia HM, Serruys PW, et al. Relationship between palpography and virtual histology in patients with acute coronary syndromes. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S19–27.PubMedCrossRef
18.
go back to reference Stone PH, Saito S, Takahashi S, et al. Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION study. Circulation. 2012;126(2):172–81.PubMedCrossRef Stone PH, Saito S, Takahashi S, et al. Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION study. Circulation. 2012;126(2):172–81.PubMedCrossRef
19.
go back to reference Maurovich-Horvat P, Schlett CL, Alkadhi H, et al. Differentiation of early from advanced coronary atherosclerotic lesions: systematic comparison of CT, intravascular US, and optical frequency domain imaging with histopathologic examination in ex vivo human hearts. Radiology. 2012;265(2):393–401.PubMedCrossRef Maurovich-Horvat P, Schlett CL, Alkadhi H, et al. Differentiation of early from advanced coronary atherosclerotic lesions: systematic comparison of CT, intravascular US, and optical frequency domain imaging with histopathologic examination in ex vivo human hearts. Radiology. 2012;265(2):393–401.PubMedCrossRef
20.
go back to reference Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 2012;59(12):1058–72.PubMedCrossRef Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 2012;59(12):1058–72.PubMedCrossRef
21.
go back to reference Rathore S, Terashima M, Matsuo H, et al. Association of coronary plaque composition and arterial remodelling: a optical coherence tomography study. Atherosclerosis. 2012;221(2):405–15.PubMedCrossRef Rathore S, Terashima M, Matsuo H, et al. Association of coronary plaque composition and arterial remodelling: a optical coherence tomography study. Atherosclerosis. 2012;221(2):405–15.PubMedCrossRef
22.
go back to reference Kato K, Yonetsu T, Kim SJ, et al. Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study. JACC Cardiovasc Interv. 2012;5(11):1150–8.PubMedCrossRef Kato K, Yonetsu T, Kim SJ, et al. Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study. JACC Cardiovasc Interv. 2012;5(11):1150–8.PubMedCrossRef
23.
go back to reference Hattori K, Ozaki Y, Ismail TF, et al. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging. 2012;5(2):169–77.PubMedCrossRef Hattori K, Ozaki Y, Ismail TF, et al. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging. 2012;5(2):169–77.PubMedCrossRef
24.
go back to reference Kato K, Yonetsu T, Kim SJ, et al. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging. 2012;5(4):433–40.PubMedCrossRef Kato K, Yonetsu T, Kim SJ, et al. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging. 2012;5(4):433–40.PubMedCrossRef
25.
go back to reference • Prati F, Uemura S, Souteyrand G, et al. OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging. 2013;6(3):283–7. Thirty-one ST-elevation MI patients with nonobstructive culprit CAD following aspiration thrombectomy and OCT-defined plaque erosion (intact culprit lesion fibrous cap) were treated with percutaneous coronary stenting or dual-antiplatelet therapy alone. After more than 2 years’ follow-up, no death or recurrent MI was observed in either group.PubMedCrossRef • Prati F, Uemura S, Souteyrand G, et al. OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging. 2013;6(3):283–7. Thirty-one ST-elevation MI patients with nonobstructive culprit CAD following aspiration thrombectomy and OCT-defined plaque erosion (intact culprit lesion fibrous cap) were treated with percutaneous coronary stenting or dual-antiplatelet therapy alone. After more than 2 years’ follow-up, no death or recurrent MI was observed in either group.PubMedCrossRef
26.
go back to reference Patel D, Hamamdzic D, Llano R, et al. Subsequent development of fibroatheromas with inflamed fibrous caps can be predicted by intracoronary near infrared spectroscopy. Arterioscler Thromb Vasc Biol. 2013;33(2):347–53.PubMedCrossRef Patel D, Hamamdzic D, Llano R, et al. Subsequent development of fibroatheromas with inflamed fibrous caps can be predicted by intracoronary near infrared spectroscopy. Arterioscler Thromb Vasc Biol. 2013;33(2):347–53.PubMedCrossRef
27.
go back to reference Buxton DB, Antman M, Danthi N, et al. Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging. Circulation. 2011;123(19):2157–63.PubMedCrossRef Buxton DB, Antman M, Danthi N, et al. Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging. Circulation. 2011;123(19):2157–63.PubMedCrossRef
28.
go back to reference Kerwin W, Alessio A, Ferguson M, et al. High-resolution [18]fluorodeoxyglucose-positron emission tomography and coregistered magnetic resonance imaging of atherosclerotic plaque from a patient undergoing carotid endarterectomy. Circ Cardiovasc Imaging. 2012;5(5):683–4.PubMedCrossRef Kerwin W, Alessio A, Ferguson M, et al. High-resolution [18]fluorodeoxyglucose-positron emission tomography and coregistered magnetic resonance imaging of atherosclerotic plaque from a patient undergoing carotid endarterectomy. Circ Cardiovasc Imaging. 2012;5(5):683–4.PubMedCrossRef
29.
go back to reference Bucerius J, Mani V, Moncrieff C, et al. Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake. J Am Coll Cardiol. 2012;59(23):2080–8.PubMedCrossRef Bucerius J, Mani V, Moncrieff C, et al. Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake. J Am Coll Cardiol. 2012;59(23):2080–8.PubMedCrossRef
30.
go back to reference Myers KS, Rudd JH, Hailman EP, et al. Correlation between arterial FDG uptake and biomarkers in peripheral artery disease. JACC Cardiovasc Imaging. 2012;5(1):38–45.PubMedCrossRef Myers KS, Rudd JH, Hailman EP, et al. Correlation between arterial FDG uptake and biomarkers in peripheral artery disease. JACC Cardiovasc Imaging. 2012;5(1):38–45.PubMedCrossRef
31.
go back to reference •• Marnane M, Merwick A, Sheehan OC, et al. Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol. 2012;71(5):709–18. In 60 patients with recent TIA or stroke, elevated FDG PET signal in the ipsilateral culprit carotid artery was the only independent predictor of early recurrent cerebrovascular ischemia within 90 days of the index event.PubMedCrossRef •• Marnane M, Merwick A, Sheehan OC, et al. Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol. 2012;71(5):709–18. In 60 patients with recent TIA or stroke, elevated FDG PET signal in the ipsilateral culprit carotid artery was the only independent predictor of early recurrent cerebrovascular ischemia within 90 days of the index event.PubMedCrossRef
32.
go back to reference Figueroa AL, Subramanian SS, Cury RC, et al. Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology. Circ Cardiovasc Imaging. 2012;5(1):69–77.PubMedCrossRef Figueroa AL, Subramanian SS, Cury RC, et al. Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology. Circ Cardiovasc Imaging. 2012;5(1):69–77.PubMedCrossRef
33.
go back to reference Cheng VY, Slomka PJ, Le Meunier L, et al. Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneous stenting for acute myocardial infarction and stable coronary artery disease. J Nucl Med. 2012;53(4):575–83.PubMedCrossRef Cheng VY, Slomka PJ, Le Meunier L, et al. Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneous stenting for acute myocardial infarction and stable coronary artery disease. J Nucl Med. 2012;53(4):575–83.PubMedCrossRef
34.
go back to reference Elkhawad M, Rudd JH, Sarov-Blat L, et al. Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. JACC Cardiovasc Imaging. 2012;5(9):911–22.PubMedCrossRef Elkhawad M, Rudd JH, Sarov-Blat L, et al. Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. JACC Cardiovasc Imaging. 2012;5(9):911–22.PubMedCrossRef
35.
go back to reference Bissonnette R, Tardif JC, Harel F, et al. Effects of the tumor necrosis factor-alpha antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial. Circ Cardiovasc Imaging. 2013;6(1):83–90.PubMedCrossRef Bissonnette R, Tardif JC, Harel F, et al. Effects of the tumor necrosis factor-alpha antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial. Circ Cardiovasc Imaging. 2013;6(1):83–90.PubMedCrossRef
36.
go back to reference • Dweck MR, Chow MW, Joshi NV, et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol. 2012;59(17):1539–48. NaF molecular imaging identifies sites of active coronary calcification noninvasively by PET and may be a new therapeutic target. The NaF signal was elevated in proportion to coronary CT calcium scores in 119 subjects, except in those with the highest calcium scores that may represent end-stage calcified plaques.PubMedCrossRef • Dweck MR, Chow MW, Joshi NV, et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol. 2012;59(17):1539–48. NaF molecular imaging identifies sites of active coronary calcification noninvasively by PET and may be a new therapeutic target. The NaF signal was elevated in proportion to coronary CT calcium scores in 119 subjects, except in those with the highest calcium scores that may represent end-stage calcified plaques.PubMedCrossRef
37.
go back to reference Gaemperli O, Shalhoub J, Owen DR, et al. Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J. 2012;33(15):1902–10.PubMedCrossRef Gaemperli O, Shalhoub J, Owen DR, et al. Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J. 2012;33(15):1902–10.PubMedCrossRef
38.
go back to reference Opalinska M, Stompor T, Pach D, et al. Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients. Eur J Nucl Med Mol Imaging. 2012;39(4):673–82.PubMedCrossRef Opalinska M, Stompor T, Pach D, et al. Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients. Eur J Nucl Med Mol Imaging. 2012;39(4):673–82.PubMedCrossRef
39.
go back to reference Jaffer FA, Calfon MA, Rosenthal A, et al. Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J Am Coll Cardiol. 2011;57(25):2516–26.PubMedCrossRef Jaffer FA, Calfon MA, Rosenthal A, et al. Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J Am Coll Cardiol. 2011;57(25):2516–26.PubMedCrossRef
40.
go back to reference Yoo H, Kim JW, Shishkov M, et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med. 2011;17(12):1680–4.PubMedCrossRef Yoo H, Kim JW, Shishkov M, et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med. 2011;17(12):1680–4.PubMedCrossRef
41.
go back to reference • Vinegoni C, Botnaru I, Aikawa E, et al. Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques. Sci Transl Med. 2011;3(84):84ra45. The FDA-approved NIRF imaging agent ICG was demonstrated to localize within lipid-rich atherosclerotic lesions. ICG molecular imaging of atheroma with new specialized intravascular catheters may allow detailed in vivo characterization of high-risk plaques.PubMedCrossRef • Vinegoni C, Botnaru I, Aikawa E, et al. Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques. Sci Transl Med. 2011;3(84):84ra45. The FDA-approved NIRF imaging agent ICG was demonstrated to localize within lipid-rich atherosclerotic lesions. ICG molecular imaging of atheroma with new specialized intravascular catheters may allow detailed in vivo characterization of high-risk plaques.PubMedCrossRef
Metadata
Title
Imaging Atherosclerosis and Risk of Plaque Rupture
Authors
Eric A. Osborn
Farouc A. Jaffer
Publication date
01-10-2013
Publisher
Springer US
Published in
Current Atherosclerosis Reports / Issue 10/2013
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-013-0359-z

Other articles of this Issue 10/2013

Current Atherosclerosis Reports 10/2013 Go to the issue

Lipid and Metabolic Effects of Gastrointestinal Surgery (F Rubino, Section Editor)

Diabetes Remission Following Metabolic Surgery: Is GLP-1 the Culprit?

Lipid and Metabolic Effects of Gastrointestinal Surgery (FR Rubino, Section Editor)

Role of Metabolic Surgery in Less Obese or Non-Obese Subjects with Type 2 Diabetes: Influence Over Cardiovascular Events

Clinical Trials and Their Interpretations (J Plutzky, Section Editor)

Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator

Clinical Trials and Their Interpretations (J Plutzky, Section Editor)

Multiple Adipose Depots Increase Cardiovascular Risk via Local and Systemic Effects

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.